A REIT With Great V...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$104.53 0.29 | 0.28%
05/22/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 4.34B | 3.68B | 4.63B | 4.60B |
| Operating Gains/Losses | 0.00 | 63.00M | 0.00 | 111.00M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 348.00M | -557.00M | -210.00M | -36.00M |
| (Increase) Decrease in Inventories | -150.00M | -383.00M | 153.00M | -134.00M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | -3.00M |
| (Decrease) Increase In Payables | 161.00M | -95.00M | 142.00M | 71.00M |
| (Decrease) Increase In Other Current Liabilities | 87.00M | -20.00M | -504.00M | 178.00M |
| (Increase) Decrease In Other Working Capital | -491.00M | 1.42B | 118.00M | 33.00M |
| Other Non-Cash Items | 466.00M | 347.00M | 611.00M | 415.00M |
| Net Cash From Continuing Operations | 5.88B | 5.12B | 5.79B | 6.34B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 5.88B | 5.12B | 5.79B | 6.34B |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 19.37B | 21.62B | 11.13B | 9.70B |
| Purchases of Property, Plant & Equipment | -689.00M | -567.00M | -580.00M | -530.00M |
| Acquisitions | -2.39B | -701.00M | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -26.24B | -21.18B | -14.60B | -12.42B |
| Other Cash from Investing Activities | -36.00M | 45.00M | -97.00M | 51.00M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -9.99B | -786.00M | -4.15B | -3.20B |
| Issuance of Debt | 4.93B | 11.15B | 2.47B | 1.98B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.29B | 0.00 | 80.00M | 171.00M |
| Repayment of Long-Term Debt | -123.00M | -3.26B | 0.00 | -1.00B |
| Repurchase of Capital Stock | -4.61B | -8.32B | -3.79B | -3.21B |
| Payment of Cash Dividends | -1.12B | -500.00M | 0.00 | 0.00 |
| Other Financing Charges, Net | 46.00M | 254.00M | 3.00M | 33.00M |
| Net Cash From Financing Activities | 419.00M | -674.00M | -1.23B | -2.02B |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -3.69B | 3.66B | 403.00M | 1.11B |
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- Amgen Inc (AMGN): Today's Featured Health Care Winner 05.21.13 | 05:05 pm
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Drugs Winner 05.14.13 | 05:05 pm
- 5 Stocks Going Ex-Dividend Tomorrow: HR, PMT, CNP, GG, AMGN 05.13.13 | 10:05 am
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) 05.13.13 | 09:05 am
- Amgen Inc (AMGN): Today's Featured Health Care Laggard 05.06.13 | 05:05 pm
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- All the Reasons in the World to Pull Back 05.04.13 | 06:05 am
- Analysts' Actions: AMGN BIIB DWA FCX ULTI 05.01.13 | 08:05 am
- BMY, CELG And AMGN, 3 Drugs Stocks Pushing The Industry Lower 04.29.13 | 01:04 pm
Press Releases for AMGN
- Amgen Announces Voting Results Of Annual Meeting Of Stockholders - PR Newswire 05.22.13 | 05:05 pm
- Amgen To Present At The UBS Global Life Sciences Conference - PR Newswire 05.16.13 | 04:05 pm
- Amgen Highlights Data To Be Presented At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - PR Newswire 05.09.13 | 04:05 pm
- Four Californians Selected As Breakaway From Cancer® Champions To Be Honored During Amgen Tour Of California - PR Newswire 05.01.13 | 04:05 pm
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
- Amgen To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 04:03 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
